跳至主要内容
临床试验/NCT00673140
NCT00673140Unknown1 期

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's Disease

GAAD Medical Research Institute Inc.2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2008年5月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
7
试验地点
2
主要终点
Therapy for ALS

研究概览

简要总结

Amyotrophic Lateral Sclerosis (ALS, sometimes called Lou Gehrig's s Disease, or Maladie de Charcot) is a progressive, usually fatal, neurodegenerative disease caused by the degeneration of motor neurons, the nerve cells in the central nervous system that control voluntary muscle movement.

This study will investigate the use of far infrared radiation for the control, management and treatment of ALS.

详细描述

As a motor neuron disease, ALS causes muscle weakness and atrophy throughout the body as both the upper and lower motor neurons degenerate, ceasing to send messages to muscles. Unable to function, the muscles gradually weaken, develop fasciculations (twitches) because of denervation, and eventually atrophy due to that denervation. The patient may ultimately lose the ability to initiate and control all voluntary movement except of the eyes.

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.

It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have ALS.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with ALS

排除标准

  • 未提供

结局指标

主要结局

Therapy for ALS

时间窗: 2 years

次要结局

  • Rehabilitation of ALS patients(2 Years)

研究者

发起方
GAAD Medical Research Institute Inc.
申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Far Infrared Irradiation for Control, Management and... | 临床试验